BackHeidelberg Pharma AG Overview

Heidelberg Pharma AG Common Stock

Heidelberg Pharma AG's common stock is $47M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$46.78M
↑ 0.00% YoYΔ $0.00 vs prior year quarter

Peer trimmed avg / median

Loading

Heidelberg Pharma AG Common Stock History

Loading

Heidelberg Pharma AG vs. peers: Common Stock Comparison

Loading

Heidelberg Pharma AG Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Heidelberg Pharma AG (HPHA.DE) FAQ

As of the most recent data (August 2026), HPHA.DE shows a common stock of $47M. That compares with $47M in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HPHA.DE's common stock is now $47M (was $47M) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Heidelberg Pharma AG is outperforming or lagging.

Tracking HPHA.DE's common stock over time shows whether Heidelberg Pharma AG is scaling, shrinking, or reshaping that part of the business. The current reading is $47M That compares with $47M in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Heidelberg Pharma AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $47M) with ownership activity and broader fundamentals.

Heidelberg Pharma AG's common stock is $47M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.